For Bain Capital Stanton Edward de Sciora (646) 502-3538 [email protected] Share this page. With 57 offices in 36 countries, Bain has worked with the majority of the Global 500, thousands of major regional and local companies, and private equity funds representing 75 percent of global equity capital. The Healthcare Private Equity Association (HCPEA) is a nonprofi t trade association 501(c)(6) whose mission is to support the reputation, knowledge and relationships of the healthcare private equity community. We maintain a global network of more than 1,000 experienced professionals serving PE clients. Page i Dear Colleague: Welcome to Bain & Company’s fi rst Global Healthcare Private Equity Report. Flexible contracts, modular manufacturing and improved network visibility help reduce risk. Bain Capital Private Equity believes that industry trends are creating investment opportunities for well-managed, low-cost, high-quality healthcare companies. Share this: Twitter; LinkedIn ; TAGS; Asia-Pacific; trends & research; MOST RECENT. He is a Vice President in the Healthcare Vertical and a member of the North American Private Equity team. “To get deals done amid intense competition, funds took more creative approaches to transactions,” said Kara Murphy, who co-leads Bain & Company’s Healthcare Private Equity practice. We can help you scale and build highly efficient commercialization engines to help your company grow faster on less dilution. About Bain & Company’s Private Equity business Bain & Company is the leading consulting partner to the private equity (PE) industry and its stakeholders. Bain Capital Private Equity’s global team of approximately 220 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer/retail, financial and business services, industrials, and technology, media and telecommunications. At a Glance. We maintain a global network of more than 1,000 experienced professionals serving PE clients. Investors are also expanding their value-creation theses beyond traditional category- or geographic-leadership buyouts to address the challenge of multiple expansion likely becoming an outdated lever for returns.”. Go-to-Market Expertise. It faces the new reality that the high, noncyclical growth rates it has enjoyed in the past are unlikely to continue, given global pressures to contain healthcare costs. Please select an industry from the dropdown list. This followed the spike in activity from 2012 to 2015, as funds now have cleared their books of the vast majority of assets acquired prior to the past recession. Disclosed exit value fell to $31.6 billion in 2018 from $44.4 billion in 2017, driven by a 43 percent decline in the value of exits to corporates. Bain Capital Private Equity (BCPE), is the private equity investment arm of alternative asset management firm, Bain Capital. Gene therapy could reach full potential in the next 5 to 10 years—but first, there are technological and operational challenges to overcome. Prior to joining Bain Capital, Mr. Kazarinoff was a consultant at The Boston Consulting Group, where he served clients in the private equity, consumer and healthcare industries. According to Bain & Company, investors need to expand, accelerate, and intensify their process for buyouts, guided by four principles: Develop a clear playbook and the right capabilities for the chosen strategy. Founded in 1983, Bain is based in Boston and employs over 1,000 at its global offices. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes …

Too Human Pre Order Armor Sets, Fallout 4 Confidence Man Bug, Sunny Vickers Death, Witcher 3 Workshop, How Much Is €50 In Naira,